Epiminder (ASX:EPI) Buyback Yield %: -165,824.64 (As of Jun. 30, 2026)


ASX:EPI Epiminder Ltd ASX:EPI
17 GF Score
Price A$0.32
View Full Analysis

What is Epiminder Buyback Yield %?

Epiminder ASX:EPI +1.59% 17 Buyback Yield % is -165,824.64 as of Jun. 30, 2026. GuruFocus rates ASX:EPI with a GF Score™ of 17/100. Among 345 Medical Devices & Instruments companies, Epiminder ranks worse than 100% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Epiminder's current buyback yield was -165,824.64%.

Epiminder Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Epiminder's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epiminder Buyback Yield % Chart

Epiminder Annual Data
Trend Jun23 Jun24 Jun25
Buyback Yield %
0.00 0.00 0.00

Epiminder Semi-Annual Data
Jun23 Jun24 Jun25 Dec25
Buyback Yield % 0.00 0.00 0.00 -51,693.77

ASX:EPI vs ABT, SYK, MDT: Buyback Yield % Comparison

For the Medical Devices subindustry, Epiminder's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epiminder Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epiminder's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Epiminder's Buyback Yield % falls into.


ASX:EPI
17GF Score
Epiminder Ltd ASX:EPI
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epiminder Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Epiminder's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 0
=N/A%

Epiminder's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-10.581 + 125) / 0.22134
=-51,693.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -165,824.64 mean?
Epiminder (ASX:EPI) has a Buyback Yield % of -165,824.64 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Epiminder and its competitors. According to the industry distribution chart, Epiminder ranks #345 out of 345 companies in the Medical Devices & Instruments industry.
Is Epiminder's Buyback Yield % too high?
Epiminder's current Buyback Yield % is -165,824.64. Based on the distribution chart, Epiminder ranks #345 out of 345 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Epiminder has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Epiminder's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epiminder ranks #345 out of 345 companies for Buyback Yield %. This places Epiminder in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Epiminder and its competitors. Epiminder's current Buyback Yield % is -165,824.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epiminder stock overvalued right now?
Epiminder (ASX:EPI) has a current Buyback Yield % of -165,824.64. The current Buyback Yield % is -165,824.64. Epiminder's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Epiminder (ASX:EPI), the current Buyback Yield % is -165,824.64 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epiminder Business Description

Address 525 Collins Street, 210 West Podium, Mezzanine 2, Melbourne, VIC, AUS, 3000
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
17GF Score

Get the complete analysis for ASX:EPI

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.32
Price